News
- Oculis Announces Successful End-of-Phase 2 Meeting with the FDA for OCS-01 in Two Ophthalmology Indications
07/27/2020 / 14:00 - GlobeNewswire
-
- Verrica Pharmaceuticals Announces Clinical and Drug Development Leadership Changes
07/23/2020 / 13:30 - GlobeNewswire
-
- SEC Charges Novartis AG with FCPA Violations
06/25/2020 / 18:51 - Newsfile Corp
-
- Founder and Former Chairman & CEO of Exact Sciences Stanley Lapidus Joins PAVmed Subsidiary Lucid Diagnostics as Strategic Advisor
06/15/2020 / 15:30 - GlobeNewswire
-
- Aerpio Hosting Key Opinion Leader Call on a Novel Mechanism for the Treatment of Glaucoma
06/08/2020 / 15:00 - GlobeNewswire
-
- CENTOGENE Announces Changes in Senior Management Team
05/15/2020 / 12:30 - GlobeNewswire
-
- BioELife Corp. Establishes Advisory Board for Research and Development of Products to Help Defend Against Virus (COVID-19) and Bacteria Contamination
03/20/2020 / 13:30 - GlobeNewswire
-
- Nicox to Receive €15 Million and Half of the Cost of the Second NCX 470 Phase 3 Clinical Trial from Ocumension Therapeutics under Amended Agreement
03/11/2020 / 07:30 - GlobeNewswire
-
- Precision BioSciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update
03/10/2020 / 12:05 - GlobeNewswire
-
- Earth Science Tech, Inc. (ETST) Announces Cancellation of 18,000,000 Common and 5,200,000 Preferred Shares, Updating the Outstanding Shares to 36,384,394 from 53,902,354
02/06/2020 / 14:30 - GlobeNewswire
Real-time